We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years.
- Authors
Wickens, K; Black, P; Stanley, T V; Mitchell, E; Barthow, C; Fitzharris, P; Purdie, G; Crane, J
- Abstract
Using a double blind randomized placebo-controlled trial (Australian New Zealand Clinical Trials Registry: ACTRN12607000518460), we have shown that in a high risk birth cohort, maternal supplementation from 35 weeks gestation until 6 months if breastfeeding and infant supplementation until 2 years with Lactobacillus rhamnosus HN001 (HN001) (6 × 10(9) cfu/day) halved the cumulative prevalence of eczema by age 2 years. Bifidobacterium animalis subsp lactis HN019 (HN019) (9 × 10(9) cfu/day) had no effect.
- Publication
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2012, Vol 42, Issue 7, p1071
- ISSN
1365-2222
- Publication type
Journal Article
- DOI
10.1111/j.1365-2222.2012.03975.x